Overview
Bile acid synthesis defects with cholestasis and malabsorption represent a group of rare inherited metabolic disorders in which the liver cannot properly produce bile acids due to deficiencies in specific enzymes involved in the bile acid biosynthetic pathway. Bile acids are essential for the digestion and absorption of dietary fats and fat-soluble vitamins (A, D, E, and K) in the intestine, and they also play a critical role in regulating bile flow from the liver. When bile acid synthesis is impaired, toxic intermediate metabolites accumulate in the liver, leading to progressive cholestasis (impaired bile flow), liver damage, and fat malabsorption. Key clinical features typically present in infancy or early childhood and include prolonged neonatal jaundice, hepatomegaly (enlarged liver), steatorrhea (fatty stools), failure to thrive, and fat-soluble vitamin deficiencies that can cause rickets, coagulopathy, and neurological problems. Progressive liver disease may develop, potentially leading to cirrhosis and liver failure if untreated. Laboratory findings often show elevated serum transaminases, conjugated hyperbilirubinemia, and characteristically low or absent serum levels of primary bile acids, with abnormal bile acid metabolites detectable in urine by mass spectrometry. Treatment depends on the specific enzymatic defect but may include oral bile acid replacement therapy, most commonly with cholic acid or chenodeoxycholic acid. This approach can suppress the production of toxic bile acid intermediates, improve bile flow, and correct fat-soluble vitamin malabsorption. Cholic acid (marketed as Cholbam in the United States) has been approved for certain bile acid synthesis disorders. Supplementation with fat-soluble vitamins is also an important component of management. In severe or refractory cases, liver transplantation may be considered. Early diagnosis and treatment are critical, as timely intervention can prevent progressive liver damage and significantly improve outcomes.
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Bile acid synthesis defect with cholestasis and malabsorption.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Bile acid synthesis defect with cholestasis and malabsorption at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Bile acid synthesis defect with cholestasis and malabsorption.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Bile acid synthesis defect with cholestasis and malabsorption.
Community
No community posts yet. Be the first to share your experience with Bile acid synthesis defect with cholestasis and malabsorption.
Start the conversation →Latest news about Bile acid synthesis defect with cholestasis and malabsorption
No recent news articles for Bile acid synthesis defect with cholestasis and malabsorption.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Bile acid synthesis defect with cholestasis and malabsorption
What is Bile acid synthesis defect with cholestasis and malabsorption?
Bile acid synthesis defects with cholestasis and malabsorption represent a group of rare inherited metabolic disorders in which the liver cannot properly produce bile acids due to deficiencies in specific enzymes involved in the bile acid biosynthetic pathway. Bile acids are essential for the digestion and absorption of dietary fats and fat-soluble vitamins (A, D, E, and K) in the intestine, and they also play a critical role in regulating bile flow from the liver. When bile acid synthesis is impaired, toxic intermediate metabolites accumulate in the liver, leading to progressive cholestasis (
How is Bile acid synthesis defect with cholestasis and malabsorption inherited?
Bile acid synthesis defect with cholestasis and malabsorption follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Bile acid synthesis defect with cholestasis and malabsorption typically begin?
Typical onset of Bile acid synthesis defect with cholestasis and malabsorption is neonatal. Age of onset can vary across affected individuals.